Pillar 3: Strategy & Digital

Pillar 3: Strategy & Digital
Product Description

Our services for vigilance & Safety:EU QPPV and LPPV/LSO
Pharmacovigilance Consulting
Case Management
Regulatory Medical Writing
Medical Information
Literature Watch
Cosmetovigilance
Medical Devices and IVD Vigilance

ProductLife Group

  • FR
  • 2023
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Consultancy
Primary activities
Other
Specifications
  • Details
    STRATEGIC CONSULTING
    • Growth StrategyStrategic Market Access
    • Business Development and Licensing


    BUSINESS TRANSFORMATION AND COMMERCIAL EXCELLENCE
    • Target Operating Model
    • Manufacturing and Supply Chain
    • Operational Excellence



    DIGITAL AND IT SERVICES
    • Data Governance and Data Model
    • IT Project Management and Implementation
    • Run and Service Desk
    • Advanced Solution for Digital Innovation
    • Computer System Validation (CSV)

ProductLife Group

  • FR
  • 2023
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Consultancy
Primary activities
Other

More Products from ProductLife Group (2)

  • Pillar 1: Product Development

    Product Pillar 1: Product Development

    Our services for Quality & Compliance:

    - CMC Pre and Postapproval
    - Quality Systems Consulting and Operational Quality Assurance
    - Audits and Inspection Readiness
    - Management of Compliance



  • Pillar 2: Life Cycle Management

    Product Pillar 2: Life Cycle Management

    Central and Local Outsourcing Operating ModelPromotional Materials
    Product Marketing Authorization and Life Cycle Management
    Pre Marketing Approval Support
    Interaction with Global Health Authorities
    Health-Care Compliance – France
    Regulatory Intelligence & Strategy Building

ProductLife Group resources (2)

  • News Product Development Trends for a Changing Market: Breakfast Session Bulletin

    Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners, the CPHI North America Breakfast Sessions had something for everyone looking to fill their brains and their stomachs.    
  • Whitepaper ARTIFICIAL INTELLIGENCE (AI) IN PHARMACOVIGILANCE: DO WE REALLY NEED IT…?

    There seems to be a lack of clarity about the meaning of terms such as “artificial intelligence (AI)”, “machine learning (ML)”, “data science (DS)” and “office automation (OA)”, which should not be used interchangeably. Pharmacovigilance (PV) represents a very interesting field in this regard, since it poses some unique technical challenges. For example, the “signal to noise ratio” and the “quality of the information” are very different in reports from clinical trials and in information coming from social networks, smartphone apps or smartwatches, and therefore require different approaches. Case processing, moreover, requires a mix of administrative and repetitive tasks (e.g. data cleaning and form filling) and tasks that require a high level of experience and specialization (e.g. medical reviews and signal detection). For more information, contact us.